Y-Intercept (HK)’s Boston Scientific BSX Stock Holding History

Y-Intercept (HK)’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.53M	Sell	126,685 -993,646	-89%	-$46M	0.12%	200
2026 Q2	$47.8M	Buy	1,120,331 +670,060	+149%	+$36.4M	0.95%	3
2026 Q1	$28.3M	Buy	450,271 +387,819	+621%	+$31M	0.54%	9
2025 Q4	$5.95M	Buy	+62,452	New	+$6.12M	0.13%	176
2023 Q2	–	Sell	-48,645	Closed	-$2.43M	–	1291
2023 Q1	$2.43M	Buy	48,645 +43,380	+824%	+$2.04M	0.28%	60
2022 Q4	$244K	Buy	+5,265	New	+$228K	0.04%	746
2022 Q2	–	Sell	-23,254	Closed	-$1.03M	–	878
2022 Q1	$1.03M	Buy	+23,254	New	+$1.01M	0.24%	110
2021 Q3	–	Sell	-14,634	Closed	-$626K	–	660
2021 Q2	$626K	Buy	14,634 +2,506	+21%	+$105K	0.16%	209
2021 Q1	$473K	Buy	+12,128	New	+$459K	0.13%	269

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Y-Intercept (HK)'s BSX Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Boston Scientific (BSX) stake by 89% in Q3 2026, selling an estimated $46M and leaving 126,685 shares worth $5.53M. The position accounts for 0.12% of the portfolio, ranked #200.

Y-Intercept (HK) first reported a position in BSX in Q1 2021 and has held it in 9 quarters since. The position peaked at $47.8M in Q2 2026. 260 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Y-Intercept (HK) held 126,685 shares of Boston Scientific worth $5.53M as of Q3 2026.
Y-Intercept (HK) sold 993,646 Boston Scientific shares in Q3 2026, an estimated $46M.
Boston Scientific made up 0.12% of Y-Intercept (HK)'s portfolio in Q3 2026, its #200 holding.
Y-Intercept (HK) first reported a position in Boston Scientific in Q1 2021 and has held it in 9 quarters since.
Y-Intercept (HK)'s Boston Scientific position peaked at $47.8M in Q2 2026.
260 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.